The Wolf Administration released applications for entities to become Clinical Registrants (CRs) as part of the research portion of the state’s medical marijuana program.
“We are looking forward to working with high-quality clinical registrants who will ensure that the research portion of the medical marijuana program is second to none,” Secretary of Health Dr. Rachel Levine said. “These entities will work alongside the Academic Clinical Research Centers (ACRCs) to ensure that patients with serious medical conditions get the most benefit. The work done by the ACRCs and CRs has the potential to help cancer patients, veterans and individuals who are struggling with opioid use disorder.”
The research program, guided by Act 43 of 2018, allows for eight CRs. The CR will serve as both the grower/processor and the dispensary, assisting the Academic Clinical Research Centers (ACRCs) with providing and dispensing medical marijuana for research. Each potential CR must either hold or apply for, a grower/processor permit and a dispensary permit from the department. Each potential CR must also include a research contract with a certified ACRC in their application and include a description of the research program the pair intends to conduct. If approved, the CR may not hold more than one grower/processor permit and one dispensary permit. Applications are available now on the Department of Health’s medical marijuana website and must be submitted before the April 11, 2019 deadline.
More than 121,000 patients in Pennsylvania have registered to participate in the medical marijuana program, and more than 87,500 have received their identification cards and are able to purchase medical marijuana at a dispensary. In addition to patients, nearly 1500 physicians have registered for the program, 1,074 of whom have been approved as practitioners.
The medical marijuana program was signed into law by Governor Tom Wolf on April 17, 2016. Since that time, the department has:
- Completed temporary regulations to enact the program;
- Convened the Medical Marijuana Advisory Board;
- Approved six training providers for physician continuing education;
- Approved four laboratories to test this medication before it is delivered to patients;
- Registered more than 121,000 patients and issued more than 87,500 identification cards;
- Validated more than 655,000 dispensing events and nearly 1,750,000 products sold;
- Issued 25 grower/processors permits, 12 of which are operational;
- Issued 50 dispensary permits and approved 46 locations to begin operations; and
- Certified eight medical schools as Academic Clinical Research Centers.
The medical marijuana program offers medical marijuana to patients who are residents of Pennsylvania and under an approved practitioner’s care for the treatment of a serious medical condition as defined by the Medical Marijuana Law.